©The Author(s) 2020.
World J Gastrointest Oncol. Mar 15, 2020; 12(3): 311-322
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.311
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.311
Table 1 Patient characteristics
| Characteristic | n = 82 |
| Age (yr) | |
| Median (range) | 64 (34–79) |
| Sex | |
| Male | 60 (73.2) |
| Female | 22 (26.8) |
| Distance from anal verge (cm) | |
| Median (range) | 5.0 (0–8) |
| Size of tumor (cm) | |
| Median (range) | 4.5 (2–9) |
| Clinical T stage (before chemoradiotherapy) | |
| 3 | 72 (87.8) |
| 4 | 10 (12.2) |
| Mesorectal fascia invasion | |
| − | 53 (64.6) |
| + | 29 (35.4) |
| Extramural vascular invasion | |
| − | 46 (56.1) |
| + | 36 (43.9) |
| Clinical N stage (before chemoradiotherapy) | |
| − | 36 (43.9) |
| + | 46 (56.1) |
| Subgroup of locally advanced rectal cancer | |
| Bad | 50 (61.0) |
| Ugly | 32 (39.0) |
| UGT1A1 polymorphism (in 48 patients) | |
| Wild type | 25 (52.1) |
| Mutant type | 23 (47.9) |
- Citation: Kimura K, Beppu N, Doi H, Kataoka K, Yamano T, Uchino M, Ikeda M, Ikeuchi H, Tomita N. Impact of preoperative chemoradiotherapy using concurrent S-1 and CPT-11 on long-term clinical outcomes in locally advanced rectal cancer. World J Gastrointest Oncol 2020; 12(3): 311-322
- URL: https://www.wjgnet.com/1948-5204/full/v12/i3/311.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i3.311